BECN1 and glioblastoma: It has been proposed that a drop in the expression of Beclin-1 in GBM tissue enhances EGFR overexpression; therefore, higher EGFR levels and decreased levels of the protein Beclin-1 have been associated with tumor progression and a poorer prognosis [123].